Benefit-Risk Assessment of Esketamine Nasal Spray vs. Placebo in Treatment-Resistant Depression Read More > February 1, 2020
A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses Read More > January 30, 2020
Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey. Read More > January 22, 2020
Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials. Read More > January 21, 2020
Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression Read More > January 16, 2020
Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity Read More > January 13, 2020
In vivo effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in rodents: Drug discrimination and thermoregulation. Read More > January 13, 2020
Antidepressant and neurocognitive effects of serial ketamine administration versus ECT in depressed patients Read More > January 13, 2020
